Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) — Cash Flow Reinvestment Rate
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) has a Cash Flow Reinvestment Rate of 0.19x as of December 2025, reinvesting CN¥159.70 Million (capex CN¥152.89 Million plus investments CN¥-6.81 Million) from operating cash flow of CN¥837.18 Million. Check Anhui Huaren Health Pharmaceutical Co. L cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A Cash Flow Reinvestment Rate (2021–2025)
Historical reinvestment intensity for Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A across 5 annual periods. Explore Anhui Huaren Health Pharmaceutical Co. L cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (2021–2025)
Year-by-year capital reinvestment analysis for Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A. For live market cap and broader valuation context, see 301408 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.19x | CN¥159.70 Million | CN¥837.18 Million | CN¥152.89 Million | ▼ -32.4% |
| 2024 | 0.28x | CN¥161.29 Million | CN¥571.76 Million | CN¥160.89 Million | ▼ -87.6% |
| 2023 | 2.27x | CN¥298.08 Million | CN¥131.37 Million | CN¥216.31 Million | ▲ +225.7% |
| 2022 | 0.70x | CN¥121.08 Million | CN¥173.84 Million | CN¥104.77 Million | ▲ +89.8% |
| 2021 | 0.37x | CN¥51.68 Million | CN¥140.82 Million | CN¥33.91 Million | — |